Urgent Product Recall: Accu-Chek Solo cannula assembly and pump holder and Accu-Chek Solo supply kit 22 December 2022 The Therapeutic Goods Administration (TGA) and Roche Diabetes Care have issued an urgent medical device recall for Accu-Chek Solo cannula assembly and pump holder, and the supply kit. Roche Diabetes Care has identified that insulin leakage has occurred in a small number of cases with the Accu-Chek Solo cannula assembly and pump holder (6mm and 9mm, NDSS codes 851 and 852) and the Accu-Chek Solo supply kit (6mm and 9mm). Discontinue use of these products immediately. The insulin leakage may not be noticed straight away, which could lead to an under-delivery of insulin. The possible consequences could range from no clinical impact to severe hypoglycaemia (dangerously low blood glucose levels) or diabetic ketoacidosis (DKA). Please contact Roche Diabetes customer care on 1800 251 816 for information on how to return the impacted stock and receive the replacement. The complete recall notice from the TGA is available here.
News 22 May 2024 Safety put first in compounding ban Diabetes Australia welcomes the Federal Government's decision to ban replicas of weight loss medications. The safety of our community comes first. Continue Reading
Media releases 15 May 2024 Diabetes Australia welcomes cost relief in 2024-25 Federal Budget Diabetes Australia welcomes health measures providing cost of living relief in this year's Federal Budget. DA eagerly awaits the outcomes of the current Senate Inquiry into Diabetes. Continue Reading
News 14 May 2024 New PBS listing for treatment of itch associated with chronic kidney disease A new medication has been added to the PBS for people undergoing dialysis and experiencing chronic kidney disease itch. Continue Reading